Clinical

Dataset Information

0

Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors


ABSTRACT: This is a study to assess the combination of PXD101 and 5-Fluorouracil (5-FU)in patients with advanced solid tumors. The primary goal of the study is to understand the safety, anti-tumor activity, and how the study drug behaves within the body when given with 5-Fluorouracil (5-FU).

DISEASE(S): Lung Cancer,Sarcoma,Colorectal Cancer,Mesothelioma,Bladder Cancer,Breast Cancer,Lung Neoplasms,Neoplasms,Ovarian Cancer,Esophageal Neoplasms,Thyroid Cancer,Advanced Solid Tumor,Tumor,Carcinoma, Non-small-cell Lung,Head And Neck Cancer

PROVIDER: 2035464 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2017-03-27 | GSE56322 | GEO
2026-03-13 | GSE314837 | GEO
2025-03-18 | PXD051672 | Pride
2026-02-16 | PXD072095 | Pride
| PRJNA1392903 | ENA
2015-08-31 | GSE67111 | GEO
2021-03-15 | GSE168888 | GEO
2013-12-31 | E-GEOD-45866 | biostudies-arrayexpress
2022-05-05 | GSE196407 | GEO
2018-11-24 | GSE122860 | GEO